It’s surreal to see our work discussed today in physical print The Telegraph

📢 All those interested in cancer biology, cell death, immunity, immunotherapy, inflammation, RIPK1 & PROTACs, see our work published yesterday Immunity below!

If you want a quick run down of the biology in our recent Immunity paper check this thread by the incredibly talented Jonathan Mannion who spearheaded a lot of this work as part of his PhD!

Meet the six finalists chosen for Immunity's 30th anniversary cover contest: hubs.li/Q02y53pn0

Meet the six finalists chosen for Immunity's 30th anniversary cover contest: hubs.li/Q02y53Qy0

Online now: Breadth of Fc-mediated effector function correlates with clinical immunity following human malaria challenge dlvr.it/T7JVVs

A short piece by the The Telegraph on our latest work published today in Immunity Breast Cancer Now Cancer Research UK MeierLabICR The ICR

telegraph.co.uk/news/2024/05/2…

Soooooo pleased our work is finally OUT Immunity 🎷🎷🎷🎷 Thanks to the amazing team KEMRI-Wellcome Trust James O. Tuju Rodney Irene Nailain Dennis odera and many others!!! Imperial Sciences Institute of Infection Wellcome Imperial Medicine

Fantastic news was published in Immunity this month. Single-cell eosinophil development. Congrats!!
cell.com/immunity/fullt…

IL-5, promotes the expansion but not the maturation of eosinophil progenitors Immunity
cell.com/immunity/fullt…

#enjoyed reading this 'T cell-dependent autoimmunity and infection involve molecular mimicry, where the pathogen supplies a strong antigenic signal to self-reactive T cells via self-antigen crossreactivity' Ian Parish Fabio
cell.com/immunity/fullt…

Breadth of IgG Fc-mediated effector functions targeting merozoites and rings is the strongest predictor of protection (superior to growth inhibition assay) in human malaria challenge Immunity Faith Osier
cell.com/immunity/fullt…

Incredibly excited to share the 2nd instalment of my PhD work, out today in Immunity! MeierLabICR The ICR Breast Cancer Now BCNow Press Office Cancer Research UK

cell.com/immunity/fullt…

A thread, 1/

RIPK1-selective PROTAC degrader that boosts the immunostimulatory and antitumor activity of radiotherapy and immune checkpoint blockade, heating up tumors and driving long-lasting antitumor immunity Immunity Jonathan Mannion MeierLabICR The ICR
cell.com/immunity/fullt…

Here is a great lay summary of our latest work, published today Immunity MeierLabICR

Online now: A RIPK1-specific PROTAC degrader achieves potent antitumor activity by enhancing immunogenic cell death dlvr.it/T7J6TH

Study sheds light on the origin of #eosinophils and effects of current precision therapies Immunity medicalxpress.com/news/2024-05-e…

Unfortunately, we were not aware of the fantastic study from Ian Parish, Fabio, Willem Van Der Byl & colleagues Immunity 👇
We would have loved to include it as we were indeed thinking the field was missing a study like this one. Congrats again!

cell.com/immunity/abstr…

4/

Steady-state antigen recognition triggers a transcriptionally and epigenetically distinct tolerant CD8 T cell states that can be overridden by strong TCR signal + inflammation Immunity Ian Parish
cell.com/immunity/fullt…

Great new article showing how lactate promotes skin inflammation. Check it out.
cell.com/immunity/abstr…

Willem Van Der Byl Fabio Peter Mac Cancer Centre UNSW Medicine & Health Garvan Institute of Medical Research Antonio Ahn Hanjie Li Guy Ledergor Christian Deo T. Deguit Maria N. de Menezes Avi Travers KalliesLab A/Prof Paul Beavis Jungmann Lab Bastings Lab EPFL Gabrielle Belz Shom Goel Howard Chang IdoAmitLab Kavitha Scranton Link to full text here: authors.elsevier.com/a/1j7fj3qNrUxt…